نتائج البحث - Richard D. Wasnich

  • يعرض 1 - 11 نتائج من 11
تنقيح النتائج
  1. 1
    Antifracture Efficacy of Antiresorptive Agents Are Related to Changes in Bone Density

    Antifracture Efficacy of Antiresorptive Agents Are Related to Changes in Bone Density حسب Richard D. Wasnich, Paul D. Miller

    منشور في 2000
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    The effect of long-distance running upon appendicular bone mineral content

    The effect of long-distance running upon appendicular bone mineral content حسب JUDITH ANN WILLIAMS, John J. Wagner, Richard D. Wasnich, Lance K. Heilbrun

    منشور في 1984
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Effect of thiazide on rates of bone mineral loss: a longitudinal study.

    Effect of thiazide on rates of bone mineral loss: a longitudinal study. حسب Richard D. Wasnich, J. W. Davis, Philip D. Ross, John M. Vogel

    منشور في 1990
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    The Effects of Smoking on Bone Mass and the Rates of Bone Loss Among Elderly Japanese-American Men

    The Effects of Smoking on Bone Mass and the Rates of Bone Loss Among Elderly Japanese-American Men حسب John M. Vogel, James W. Davis, Abraham M. Y. Nomura, Richard D. Wasnich, Philip D. Ross

    منشور في 1997
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Changes in Bone Density and Turnover Explain the Reductions in Incidence of Nonvertebral Fractures that Occur during Treatment with Antiresorptive Agents

    Changes in Bone Density and Turnover Explain the Reductions in Incidence of Nonvertebral Fractures that Occur during Treatment with Antiresorptive Agents حسب Marc C. Hochberg, Susan L. Greenspan, Richard D. Wasnich, Paul D. Miller, Desmond Thompson, Philip D. Ross

    منشور في 2002
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Monitoring of Alendronate Treatment and Prediction of Effect on Bone Mass by Biochemical Markers in the Early Postmenopausal Intervention Cohort Study1

    Monitoring of Alendronate Treatment and Prediction of Effect on Bone Mass by Biochemical Markers in the Early Postmenopausal Intervention Cohort Study1 حسب Pernille Ravn, D. J. Hosking, Desmond Thompson, Giovanni Cizza, Richard D. Wasnich, Michael R. McClung, A.J.P. Yates, N. H. Bjarnason, Claus Christiansen

    منشور في 1999
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Prevention of Postmenopausal Bone Loss: Six-Year Results from the Early Postmenopausal Intervention Cohort Study

    Prevention of Postmenopausal Bone Loss: Six-Year Results from the Early Postmenopausal Intervention Cohort Study حسب Michael R. McClung, Richard D. Wasnich, David Hosking, Claus Christiansen, Pernille Ravn, Mei Wu, Ann Marie Mantz, John Yates, Philip D. Ross, Arthur C. Santora

    منشور في 2004
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Prevention of Bone Loss with Alendronate in Postmenopausal Women under 60 Years of Age

    Prevention of Bone Loss with Alendronate in Postmenopausal Women under 60 Years of Age حسب David Hosking, Clair E.D. Chilvers, Claus Christiansen, Pernille Ravn, Richard D. Wasnich, Philip D. Ross, Michael R. McClung, Ana Balske, Desmond Thompson, Marianne Daley, A.J.P. Yates

    منشور في 1998
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Alendronate in Early Postmenopausal Women: Effects on Bone Mass during Long-Term Treatment and after Withdrawal<sup>1</sup>

    Alendronate in Early Postmenopausal Women: Effects on Bone Mass during Long-Term Treatment and after Withdrawal<sup>1</sup> حسب Pernille Ravn, Stuart Weiss, Jose Adolfo Rodriguez-Portales, Michael R. McClung, Richard D. Wasnich, Nigel Gilchrist, Philip N. Sambrook, Ignac Fogelman, David Krupa, A.J.P. Yates, Anastasia G. Daifotis, Ghada El‐Hajj Fuleihan

    منشور في 2000
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Effect of Risedronate on the Risk of Hip Fracture in Elderly Women

    Effect of Risedronate on the Risk of Hip Fracture in Elderly Women حسب Michael R. McClung, Piet Geusens, Paul D. Miller, H Zippel, W. Bensen, Christian Roux, Silvano Adami, Ignac Fogelman, Terrence Diamond, Richard Eastell, Pierre J. Meunier, Richard D. Wasnich, Maria Greenwald, Jean‐Marc Kaufman, Charles H. Chesnut, Jean‐Yves Reginster

    منشور في 2001
    احصل على النص الكامل احصل على النص الكامل
    Carta
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis

    Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis حسب Nelson B. Watts, Steven T. Harris, Harry K. Genant, Richard D. Wasnich, Paul D. Miller, Rebecca D. Jackson, Angelo A. Licata, Philip D. Ross, Grattan C. Woodson, M. Yanover, W. Jerry Mysiw, Larry M. Kohse, MK Rao, Peter Steiger, Bradford J. Richmond, Charles H. Chesnut

    منشور في 1990
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: